The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Differentiating Sarcopenia and Cachexia Among Patients With Cancer
Abstract
Patients with cancer are at an increased risk for muscle loss via 2 distinct mechanisms: sarcopenia, defined as the age‐associated decrease in muscle mass related to changes in muscle synthesis signaling pathways, and/or cachexia, defined as cytokine‐mediated degradation of muscle and adipose depots. Both wasting disorders are prevalent; among patients with cancer, 15%–50% are sarcopenic and 25%–80% are cachectic. Muscle mass may be difficult to quantify in overweight/obese individuals. Often, overweight/obese patients with cancer are assumed to be normally nourished when in fact severe muscle depletion may be present. No universally accepted treatment exists for preventing or reversing sarcopenia or cachexia in patients with cancer. Current treatment options are limited to nutrition therapy and exercise, which may lead to difficulties in adherence during cancer treatment. Future treatments may provide pharmaceutical therapy that targets muscle degradation and synthesis pathways. There is a need to determine a multimodal treatment plan for muscle depletion to improve quality of life, survival, and therapy complications in patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“individuals with sarcopenia have impaired functional status and autonomy, which may lead to physical disabilities and higher risk for falls.(13,14) Sarcopenia is characterized by age-related changes in muscle tissue, including decreased satellite cells, atrophy of type II or fast-twitch muscle fibers, and increased mu…”
BackgroundFielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Janssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 1×
“individuals with sarcopenia have impaired functional status and autonomy, which may lead to physical disabilities and higher risk for falls.(13,14) Sarcopenia is characterized by age-related changes in muscle tissue, including decreased satellite cells, atrophy of type II or fast-twitch muscle fibers, and increased mu…”
BackgroundMuscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.004 · Cited by 1,732 · cited 2×
“The ESPEN Clinician Nutrition and Metabolism Special Interest Group recommends using bioelectrical impedance analysis (BIA) to identify low muscle mass, defined as percent muscle (skeletal muscle mass/body mass × 100) <2 standard deviations below the mean for sexand ethnicity-matched 18- to 39-year-old adults from the…”
InfluentialShen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692 · cited 1×
“001).(32) To identify sarcopenia, cross-sectional muscle area is quantified and normalized for stature (L3 skeletal muscle index, cm(2)/m(2)).”
BackgroundEffect of Vitamin D on Falls: A Meta-analysis
Bischoff-Ferrari, H. A., Dawson-Hughes, B., Willett, W. C., Staehelin, H. B., Bazemore, M. G., Zee, R. Y., & Wong, J. B. (2004) · JAMA · doi:10.1001/jama.291.16.1999 · Cited by 1,324
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Rolland, Y., Czerwinski, S., van Kan, G. A., Morley, J. E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982704 · Cited by 1,071
Sarcopenia: alternative definitions and associations with lower extremity function
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., et al. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51534.x · Cited by 981
Hughes, V. A., Frontera, W. R., Roubenoff, R., Evans, W. J., & Singh, M. A. F. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.473 · Cited by 804
Nutritional recommendations for the management of sarcopenia
Morley, J. E., Argiles, J. M., Evans, W. J., Bhasin, S., Cella, D., Deutz, N. E. P., Doehner, W., Fearon, K. C. H., Ferrucci, L., Hellerstein, M. K., et al. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.04.014 · Cited by 664
The relationship between leg power and physical performance in mobility-limited older people
Md, J. F. B., Kiely, D. K., Herman, S., Leveille, S. G., Mizer, K., Frontera, W. R., & Fielding, R. A. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50111.x · Cited by 605
Evidence for a non-linear relationship between leg strength and gait speed
BUCHNER, D. M., LARSON, E. B., WAGNER, E. H., KOEPSELL, T. D., & DE LATEUR, B. J. (1996) · Age and Ageing · doi:10.1093/ageing/25.5.386 · Cited by 542
Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review
Ali, S., & Garcia, J. M. (2014) · Gerontology · doi:10.1159/000356760 · Cited by 462 · cited 1×
“However, these medications do not influence the proinflammatory state or treat/prevent muscle wasting and have been associated with venous thromboembolism, hypogonadism, and adrenal insufficiency.(101) Selective androgen receptor modulators, ghrelin agonists, growth hormone, and myostatin inhibitors are currently bein…”
BackgroundProtein "requirements" beyond the RDA: implications for optimizing health
Phillips, S. M., Chevalier, S., & Leidy, H. J. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0550 · Cited by 396
Becker, P., Carney, L. N., Corkins, M. R., Monczka, J., Smith, E., Smith, S. E., Spear, B. A., White, J. V., Academy of Nutrition and Dietetics, & American Society for Parenteral and Enteral Nutrition (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533614557642 · Cited by 393
Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features
Jeejeebhoy, K. N. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328352694f · Cited by 226
Pharmacologic Options for the Treatment of Sarcopenia
Morley, J. E. (2016) · Calcified Tissue International · doi:10.1007/s00223-015-0022-5 · Cited by 225
Histochemical characteristics of human skeletal muscle during aging
LARSSON, L. (1983) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1983.tb00024.x · Cited by 219 · cited 1×
“Sarcopenia is characterized by age-related changes in muscle tissue, including decreased satellite cells, atrophy of type II or fast-twitch muscle fibers, and increased muscle fat infiltration.(15,16) A number of underlying mechanisms may lead to sarcopenia, including age-related neurodegeneration, impaired signaling…”
BackgroundLow Protein Intake: The Impact on Calcium and Bone Homeostasis in Humans
Kerstetter, J. E., O'Brien, K. O., & Insogna, K. L. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.3.855s · Cited by 212
DISEASE OF THE HEART IN THE WORKS OF HIPPOCRATES
Katz, A. M., & Katz, P. B. (1962) · Heart · doi:10.1136/hrt.24.3.257 · Cited by 169
Clinical implications of sarcopenic obesity in cancer
Carneiro, I. P., Mazurak, V. C., & Prado, C. M. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0546-5 · Cited by 162 · cited 2×
“Other complications associated with sarcopenic obesity include poor functional status, worse postoperative outcomes, prolonged hospitalization, and shorter survival.(47) Among patients with cancer, prevalence of sarcopenia ranges from 12%–51% when diagnosed with both body composition and functional assessment tools an…”
BackgroundThe anabolic response to resistance exercise and a protein-rich meal is not diminished by age
Symonsi, T. B., Sheffield-Moore, M., Mamerow, M. M., Wolfe, R. R., & Paddon-Jones, D. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-010-0319-z · Cited by 112 · cited 1×
“A synergistic relationship may exist between resistance exercise and protein ingestion; older adults experienced a significant increase in muscle synthesis following a high-protein meal and resistance exercise training session.(71) A number of promising medications, including selective androgen receptor modulators, gh…”
Background
Cited by
Cruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905
Sarcopenia: A Contemporary Health Problem among Older Adult Populations
Papadopoulou, S. (2020) · Nutrients · doi:10.3390/nu12051293 · Cited by 588
Bossi, P., Delrio, P., Mascheroni, A., & Zanetti, M. (2021) · Nutrients · doi:10.3390/nu13061980 · Cited by 465
Cespedes Feliciano, E. M., Kroenke, C. H., Meyerhardt, J. A., Prado, C. M., Bradshaw, P. T., Kwan, M. L., Xiao, J., Alexeeff, S., Corley, D., Weltzien, E., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2319 · Cited by 427
Management of disease-related malnutrition for patients being treated in hospital
Schuetz, P., Seres, D., Lobo, D. N., Gomes, F., Kaegi-Braun, N., & Stanga, Z. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01451-3 · Cited by 355
Metadata
- Authors
- Peterson, S. J., & Mozer, M.
- Venue
- Nutrition in Clinical Practice
- Publisher
- Wiley
- Published
- 2016-12-15
- Volume
- 32
- Issue
- 1
- Pages
- 30-39
- ISSN
- 0884-5336 (ISSN-L)
- 1941-2452
- OpenAlex
- W2580254706
- Cited by
- 191
- References
- 25
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.